Orange Book product · Generic (ANDA)
OLOPATADINE HYDROCHLORIDE
OLOPATADINE HYDROCHLORIDE
At a glance
Jul 14, 2025
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 14, 2025
11 mo ago
Today
Pharmaceutical detail
Active ingredient
OLOPATADINE HYDROCHLORIDE
Strength
EQ 0.2% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 217051
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of OLOPATADINE HYDROCHLORIDE
- 2015PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 206276 · ALCON LABS INC
- 2008PATANASEBrand (NDA)
NDA 021861 · NOVARTIS
- 2004PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 021545 · ALCON LABS INC
- 1996PATADAY TWICE DAILY RELIEFBrand (NDA)
NDA 020688 · ALCON LABS INC
- 2026OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213514 · GLAND
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219557 · GLENMARK PHARMS
- 2024OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215006 · SOMERSET
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213757 · HIKMA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204620 · RISING
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209752 · GLAND
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208637 · FLORIDA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210901 · AMNEAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
